Skip to main content
. 2017 Apr 4;2017(4):CD011387. doi: 10.1002/14651858.CD011387.pub2

1. Effect estimates for single studies.

Outcome Study/Participant Statistical method Effect estimate [95% CI] P value
Pain in the PACU (VAS) 1/n = 62 MD ‐1.00 [‐9.82 to 7.82] 0.82
Pain at 1 to 6 hours (VAS) 1/n = 62 MD ‐2.20 [‐10.62 to 6.22] 0.61
Pain at 6 to 24 hours (VAS) 1/n = 62 MD ‐1.00 [‐7.51 to 5.51] 0.76
Presence of nausea 1/n = 62 RR 0.39 [0.19 to 0.80] 0.01
Nausea intensity in PACU (VNRS) 1/n = 62 MD ‐0.70 [‐1.35 to ‐0.05] 0.03
Nausea intensity at 1 to 6 hours (VNRS) 1/n = 62 MD ‐1.70 [‐2.59 to ‐0.81] 0.0002
Nausea‐vomiting rate at 1 hour 1/n = 42 RR 23.00 [1.44 to 366.71] 0.03
Nausea‐vomiting rate at 3 hours 1/n = 42 RR 2.00 [0.20 to 20.41] 0.56
Adverse events: increase in IOP during maintenance of anaesthesia 1/n = 66 MD ‐3.90 [‐6.34 to ‐1.46] 0.002

CI: confidence interval; IOP: intraocular pressure; MD: mean difference; PACU: post‐anaesthesia care unit; RR: risk ratio; VAS: visual analogue scale; VNRS: verbal numerical rating scale.